PATENT CLAIM ANALYSIS

Application Number: 16160374
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "205100"]

Abstract:
The present invention provides fully human antibodies that bind to respiratory syncytial virus F protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing cell to cell spread of the virus, thereby providing a means of preventing the infection, or treating a patient suffering from the infection and ameliorating one or more symptoms or complications associated with the viral infection. The antibodies may also be useful for diagnosis of an infection by RSV.

Claim (Index 84):
A host cell comprising the expression vector of  claim 83 .

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.70175
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15229567', '14207797', '13827845', '16032887', '14911966']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635057617621719
- 35 USC 102 Novelty (BERT): 0.5701835098742942
- Combined Prediction Score: 0.7441735365733841
- Mean Citation Score: 401.56361
- Max Citation Score: 490.0063
- Similarity Product: 328.9330775902152

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test